Gyre Therapeutics, Inc. Increase (Decrease) in Prepaid Rent
Gyre Therapeutics, Inc. (GYRE) reported Increase (Decrease) in Prepaid Rent of -$182.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidRent · last filed 2020-02-20
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2018-12-31 was -$15.00K, a 236.36% decline year-over-year.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2018-09-30 was -$24.00K, a 340.00% decline year-over-year.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2018-06-30 was -$15.00K, a 236.36% decline year-over-year.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for the quarter ending 2018-03-31 was -$128.00K, a 1700.00% decline year-over-year.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for fiscal 2018 was -$182.00K, a 555.00% decline from fiscal 2017.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for fiscal 2017 was $40.00K, a 110.53% increase from fiscal 2016.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for fiscal 2016 was $19.00K.
- Gyre Therapeutics, Inc. increase (decrease) in prepaid rent for fiscal 2015 was -$41.00K, a 126.28% decline from fiscal 2014.
| Period end | Increase (Decrease) in Prepaid Rent 3 month | Increase (Decrease) in Prepaid Rent 6 month | Increase (Decrease) in Prepaid Rent 9 month | Increase (Decrease) in Prepaid Rent 12 month | Increase (Decrease) in Prepaid Rent 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$39.00K derived: sum of 2 quarters · filed 2020-02-20 | -$54.00K derived: sum of 3 quarters · filed 2020-02-20 | -$182.00K 10-K · filed 2020-02-20 | |
| 2018-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$39.00K derived: sum of 2 quarters · filed 2019-11-07 | -$167.00K 10-Q · filed 2019-11-07 | -$156.00K derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$143.00K 10-Q · filed 2019-08-01 | -$132.00K derived: sum of 3 quarters · filed 2019-08-01 | -$122.00K derived: sum of 4 quarters · filed 2019-08-01 | |
| 2018-03-31 | -$128.00K 10-Q · filed 2019-05-02 | -$117.00K derived: sum of 2 quarters · filed 2019-05-02 | -$107.00K derived: sum of 3 quarters · filed 2019-05-02 | -$96.00K derived: sum of 4 quarters · filed 2019-05-02 | |
| 2017-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $21.00K derived: sum of 2 quarters · filed 2019-03-08 | $32.00K derived: sum of 3 quarters · filed 2019-03-08 | $40.00K 10-K · filed 2019-03-08 | |
| 2017-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $21.00K derived: sum of 2 quarters · filed 2018-11-01 | $29.00K 10-Q · filed 2018-11-01 | $34.00K derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $19.00K 10-Q · filed 2018-08-02 | $24.00K derived: sum of 3 quarters · filed 2018-08-02 | $30.00K derived: sum of 4 quarters · filed 2018-08-02 | |
| 2017-03-31 | $8.00K 10-Q · filed 2018-05-03 | $13.00K derived: sum of 2 quarters · filed 2018-05-03 | $19.00K derived: sum of 3 quarters · filed 2018-05-03 | $24.00K derived: sum of 4 quarters · filed 2018-05-03 | |
| 2016-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $11.00K derived: sum of 2 quarters · filed 2018-03-19 | $16.00K derived: sum of 3 quarters · filed 2018-03-19 | $19.00K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $11.00K derived: sum of 2 quarters · filed 2017-11-02 | $14.00K 10-Q · filed 2017-11-02 | -$45.00K derived: sum of 4 quarters · filed 2017-11-02 | |
| 2016-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.00K 10-Q · filed 2017-08-03 | -$51.00K derived: sum of 3 quarters · filed 2017-08-03 | -$59.00K derived: sum of 4 quarters · filed 2017-08-03 | |
| 2016-03-31 | $3.00K 10-Q · filed 2017-05-11 | -$56.00K derived: sum of 2 quarters · filed 2017-05-11 | -$64.00K derived: sum of 3 quarters · filed 2017-05-11 | -$64.00K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$67.00K derived: sum of 2 quarters · filed 2017-03-08 | -$67.00K derived: sum of 3 quarters · filed 2017-03-08 | -$41.00K 10-K · filed 2017-03-08 | |
| 2015-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$8.00K derived: sum of 2 quarters · filed 2016-11-03 | $18.00K 10-Q · filed 2016-11-03 | $57.00K derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $26.00K 10-Q · filed 2016-08-04 | $65.00K derived: sum of 3 quarters · filed 2016-08-04 | $105.00K derived: sum of 4 quarters · filed 2016-08-04 | |
| 2015-03-31 | $26.00K 10-Q · filed 2016-05-05 | $65.00K derived: sum of 2 quarters · filed 2016-05-05 | $105.00K derived: sum of 3 quarters · filed 2016-05-05 | ||
| 2014-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $79.00K derived: sum of 2 quarters · filed 2016-03-09 | $156.00K 10-K · filed 2016-03-09 | $156.21K 8-K/A · filed 2015-10-23 | |
| 2014-09-30 | $40.00K derived: 10-Q 9 month − 8-K/A 6 month · filed 2015-11-05 | $117.00K 10-Q · filed 2015-11-05 | |||
| 2014-06-30 | $77.00K 8-K/A · filed 2015-10-23 | ||||
| 2013-12-31 | $138.00K 10-K · filed 2016-03-09 | $138.01K 8-K/A · filed 2015-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |